List view / Grid view
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Studies showed that Nyxoid is bioequivalent to injectable naloxone as a first line treatment for opioid overdose, with an intranasal 1.8 mg dose...
3 November 2016 | By BBI Solutions
BBI Solutions will be showcasing its Morffi™ signal enhancement technology on Stand F26 in Hall 1 at MEDICA 2016...
3 November 2016 | By METTLER TOLEDO AG
Pelago Bioscience in Solna, Sweden, is taking advantage of the enhanced process security and convenience offered by METTLER TOLEDO’s Rainin TerraRack™ pipette tip racks...
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Olipudase alfa is an enzyme replacement therapy being studied as a treatment of non-neurological manifestations of acid sphingomyelinase deficiency (ASMD)...
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Verastem licensed exclusive worldwide rights to develop and commercialise Infinity's oncology product candidate duvelisib...
3 November 2016 | By Wickham Laboratories Limited
Wickham Laboratories will be on Stand 8 at the 24th Annual Pharmig Conference in the Nottingham Belfry Hotel, November 16th & 17th...
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
NICE has said eribulin, which is also called Halaven and made by Eisai, should be an option for people with locally advanced or metastatic breast cancer...
31 October 2016 | By IFPAC
Emerging technologies to modernize pharmaceutical/biopharmaceutical development and manufacturing...
Yusen Logistics (Americas) Inc. has been recognized by the Boeing Co. for its role in coordinating shipments of relief supplies from Seattle, WA to Charleston, SC, to support Boeing employees and the local community recovering from the effects of Hurricane Matthew.
31 October 2016 | By Coulter Partners
Global Life Sciences search specialist, Coulter Partners continues to grow its business in Germany, Switzerland and Austria in response to strong market growth in the region...
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Novartis has been awarded the 2016 Prix Galien USA Award "Discovery of the Decade" Award for Best Pharmaceutical Product for the drug Gleevec, as well as...
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The Swiss Agency for Therapeutic Products, Swissmedic, has approved Alprolix (eftrenonacog alfa) for the treatment of haemophilia B...
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The US Food and Drug Administration (FDA) has approved Roche’s PD-L1 assay as a diagnostic to identify PD-L1 expression levels in patients considering treatment with Tecentriq (atezolizumab) for previously treated metastatic non-small cell lung cancer (NSCLC). The PD-L1 (SP142) assay is also indicated to identify patients with urothelial cancer (UC)…
28 October 2016 | By ESP
Enterprise System Partners (ESP) has formally signed a partnership agreement with GS1 Ireland to work collaboratively in the development and delivery of the highest anti-counterfeiting solutions based on GS1 standards to the biopharmaceutical manufacturing industry...
28 October 2016 | By ESP
In collaboration with our partners GS1 Ireland, ESP carried out an extensive industry survey to establish the status of the industry in relation to the impending serialisation deadlines, which are facing us in the coming months and years...
